Revvity, Inc. (RVTY)
(Delayed Data from NYSE)
$85.39 USD
+0.11 (0.13%)
Updated Sep 17, 2025 04:00 PM ET
After-Market: $85.45 +0.06 (0.07%) 7:58 PM ET
3-Hold of 5 3
C Value C Growth F Momentum D VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
RVTY 85.39 +0.11(0.13%)
Will RVTY be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for RVTY based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for RVTY
RVTY Posts Q2 Earnings & Sales Beat, Raises '25 Sales View
Revvity (RVTY) Q2 Earnings: How Key Metrics Compare to Wall Street Estimates
RVTY: What are Zacks experts saying now?
Zacks Private Portfolio Services
Revvity (RVTY) Surpasses Q2 Earnings and Revenue Estimates
Why Revvity (RVTY) is Poised to Beat Earnings Estimates Again
Revvity Q2 Preview: Can Strong Segments Deliver an Earnings Beat?
Other News for RVTY
RVTY's price rises by 1.52% on September 16, though its technical setup remains stable.
Analysts Offer Insights on Healthcare Companies: Ionis Pharmaceuticals (IONS), Eli Lilly & Co (LLY) and Revvity (RVTY)
RVTY rises 1.36% on September 15, leaving the technical picture intact
KeyBanc Reaffirms Their Buy Rating on Revvity (RVTY)
Is RVTY positioned for a breakdown? 180 Bearish Setup shows up after declining 3.28%